Objective: The purpose of this study was to describe the location of disease at the time of death of patients with endometrial cancer who died of their disease.
Methods: All patients with a diagnosis of endometrial cancer from January 1993 through December 2010 were included. Histologic classification was either endometrioid or high-risk (HR) endometrial cancer.